When asked, “What recent scientific discovery has fascinated you?“ my thoughts turn to the curious case of ivermectin and cancer — two seemingly unrelated entities now being linked in medical discussions (link).
As the article noted, “Ivermectin, widely known for treating parasitic infections…“ — and indeed, that is an established fact. Ivermectin was developed and prescribed as an antiparasitic drug. So how, suddenly, has it become associated with treating “cancer”? Could it be that what is being diagnosed as cancer might, in fact, be a misidentified parasitic or microbial illness?
Modern medicine has a long history of misdiagnosis — and even of creating diseases and treatments out of nothing. Virus-based illnesses provide a glaring example. There is no valid scientific evidence that viruses, as defined by medicine, actually exist; therefore, the so-called “viral diseases” cannot exist either. Yet, drugs and vaccines have been developed to treat these imaginary or mischaracterized conditions, from AIDS to COVID-19.
From both a scientific and logical perspective, cancer increasingly appears to be another case of misdiagnosis — a condition that may, in reality, stem from microbial or parasitic origins.
There is no need to plunge into speculative cell biology or chemical theorizing at this stage, especially within the medical domain, which is generally non-scientific in its approach. Physicians typically lack the training in chemistry, physics, and analytical methods required for true scientific inquiry. A prime example is the misuse of the PCR test, which, from a genuine scientific standpoint, is not a valid test at all — yet it has fueled countless false diagnoses and imaginary illnesses.
If the relationship between ivermectin and cancer is to be explored meaningfully, the inquiry should begin with a clear premise: ivermectin is an antiparasitic drug. Therefore, if it shows efficacy against cancer, the most logical conclusion is that cancer itself involves overlooked microbial — possibly parasitic — processes.
It’s time to stop creating catchy stories dressed up in pseudo-scientific language to chase research funding. Such pursuits have consumed decades and yielded little of substance — cancer research being one of the most striking examples.
————————————————————————————————-
Dr Homer Lim’s Post (link)
Ivermectin
The anti-parasitic drug that’s stirring up cancer research.
Ivermectin, widely known for treating parasitic infections, has recently gained attention for its potential anti-cancer properties. It’s a drug with a long history, now being explored for a completely new frontier.
This isn’t just about fighting parasites; it’s about uncovering a hidden talent in a familiar medicine.
But first, let me paint you a picture:
Imagine a cancer cell as a fortress, heavily guarded and self-sufficient, constantly importing resources to sustain its growth. It has complex internal machinery that allows it to evade destruction and multiply. Now, imagine a simple drug that can sneak into this fortress and disrupt its internal operations, making it vulnerable.
That’s what Ivermectin appears to do. It can interfere with various cellular processes crucial for cancer cell survival, including inhibiting cell proliferation, inducing apoptosis (programmed cell death), and disrupting cell transport mechanisms.
Here’s what nobody tells you about unexpected drug discoveries:
→ Sometimes, drugs developed for one disease can have profound effects on others.
→ The complexity of cellular pathways means a single drug can have multiple targets.
→ Repurposing existing drugs can accelerate the availability of new treatments.
The part that changed everything?
Preclinical studies have shown Ivermectin’s anti-cancer activity in various cancer types, including brain, breast, and colon cancers. Researchers believe it works by targeting multiple pathways, such as inhibiting the Wnt/β-catenin signaling pathway, disrupting mitochondrial function, and affecting the transport of certain proteins essential for cancer cell growth.
That’s when I realized: sometimes, the most groundbreaking insights come from looking at old tools with new eyes. And that a drug used for decades could hold a key to unlocking new cancer therapies.
If you’ve ever found a surprising new use for something you thought you knew well, you know this feeling.
You’re allowed to be curious about emerging research. You’re allowed to discuss all potential therapeutic avenues with your healthcare provider.
What’s a scientific discovery that has recently fascinated you? Share your thoughts below!